Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2014, Article ID 984067, 5 pages
Research Article

Substituting Doxorubicin with Nonpegylated Liposomal Doxorubicin for the Treatment of Early Breast Cancer: Results of a Retrospective Study

1Broomfield Hospital, Court Road, Chelmsford, Essex CM1 7ET, UK
2Rivers Hospital, High Wych Road, Sawbridgeworth Hertfordshire CM21 0HH, UK
3Strategen Limited, 2 & 3 Stable Court, Herriard Park Estate, Herriard, Basingstoke RG25 2PL, UK

Received 1 October 2013; Accepted 10 December 2013; Published 12 January 2014

Academic Editor: Ian S. Fentiman

Copyright © 2014 Neville Davidson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Cesare de Gregorio, Giuseppina Potenza, and Giuseppina Ferraro, “Effectiveness of the combination therapy with lisinopril, ivabradine and multivitamin supplementation in anthracycline-induced severe cardiotoxicity,” International Journal of Cardiology, 2014. View at Publisher · View at Google Scholar
  • David M. Rayner, and Suzanne M. Cutts, “Anthracyclines,” A worldwide yearly survey of new data in adverse drug reactions, vol. 36, pp. 683–694, 2014. View at Publisher · View at Google Scholar
  • Yaghoub Safdari, Vahideh Ahmadzadeh, and Safar Farajnia, “CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies,” Investigational New Drugs, 2016. View at Publisher · View at Google Scholar
  • Luigi Coltelli, Andrea Fontana, Sara Lucchesi, Laura Ginocchi, Guido Bocci, Mario Filidei, Marco Scalese, Giada Arrighi, Chiara Finale, Lorenzo Marcucci, Orlando Goletti, Barbara Salvadori, Ilaria Ferrarini, Eleonora Bona, Alfredo Falcone, and Giacomo Allegrini, “Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients,” The Breast, vol. 31, pp. 186–191, 2017. View at Publisher · View at Google Scholar
  • Ming Zhao, Xian-feng Ding, Jian-yu Shen, Xi-ping Zhang, Xiao-wen Ding, and Bin Xu, “Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice,” Journal of Zhejiang University-SCIENCE B, vol. 18, no. 1, pp. 15–26, 2017. View at Publisher · View at Google Scholar